RESUMEN
The prevalence of and risk factors for uncertainty stress among residents during the COVID-19 pandemic remain unclear. An online cross-sectional survey was conducted to explore and identify the risk factors for high perceived uncertainty stress among the general public in China during the COVID-19 outbreak. Information about the respondents' socioeconomic characteristics, knowledge of and attitudes towards COVID-19, perceived uncertainty stress, social capital, anxiety, and depressive symptoms was collected and analysed. Among the 1205 respondents, 45.3% (546) reported a high level of uncertainty stress. Multiple linear regression analysis indicated that anxiety (ß=3.871,P<0.001) and depression symptoms (ß=2.458, P<0.001), family residence (in towns or rural areas) (ß=0.947, P<0.001), lack of support for local epidemic control strategies (ß=1.253, P<0.001), worry about the pandemic (ß=1.191, P<0.001), and symptoms of weakness among family members (ß=1.525, P=0.002) were positively associated with perceived uncertainty stress. Cognitive social capital (ß=-0.883, P<0.001) and social networks (ß=-0.726, P<0.001) were negatively, but social participation (ß=0.714, P<0.001) was positively associated with perceived uncertainty stress. Our findings identify factors associated with a higher level of uncertainty stress and should be helpful in the consideration of effective policies and interventions for uncertainty stress during the initial phases of public health emergencies.
Asunto(s)
COVID-19 , Pandemias , Ansiedad/epidemiología , China/epidemiología , Estudios Transversales , Depresión/epidemiología , Humanos , SARS-CoV-2 , Encuestas y Cuestionarios , IncertidumbreRESUMEN
Objective To explore the interaction between abnormal prepregnancy body mass index(pBMI)and high blood lipid level during pregnancy on the risk of gestational diabetes mellitus(GDM). Methods A total of 235 patients with GDM and no blood lipid-related diseases before pregnancy were selected from Hangzhou Women's Hospital during March 2017 to July 2018 as the GDM group.At a ratio of 1â¶3,a total of 705 individual age-matched pregnant women with normal glucose metabolism during prenatal examination from the same hospital were selected as the control group.The generalized multifactor dimension reduction(GMDR)method was employed to characterize the possible interaction between pBMI-blood lipid and GDM.The cross-validation consistency,equilibrium test accuracy,and P value were calculated to evaluate the interaction of each model. Results GMDR model analysis showed that the second-order model including pBMI and gestational blood lipid level had the best performance(P=0.001),with the cross-validation consistency of 10/10 and the equilibrium test accuracy of 64.48%,suggesting that there was a potential interaction between pBMI and gestational high blood lipid level.After adjustment of confounding factors,the model demonstrated that overweight/obesity patients with high triglyceride(TG) level had the highest risk of developing GDM(OR=14.349,95%CI=6.449-31.924,P<0.001).Stratified analysis showed that overweight/obesity patients under high TG level group had a higher risk of developing GDM than normal weight individuals(OR=2.243,95%CI=1.173-4.290,P=0.015). Conclusions Abnormal pBMI and high blood lipid level during pregnancy are the risk factors of GDM and have an interaction between each other.Overweight/obese pregnant women with high TG levels are more likely to develop GDM.
Asunto(s)
Diabetes Gestacional , Hiperlipidemias , Índice de Masa Corporal , Femenino , Humanos , Hiperlipidemias/complicaciones , Obesidad/complicaciones , Sobrepeso , EmbarazoRESUMEN
The present study evaluated the effect of Shenqi Jiangtang Granules(SJG) combined with western medicine on the adverse pregnancy outcomes in women with gestational diabetes mellitus(GDM). PubMed, Web of Science, CNKI, Wanfang, and VIP were searched for clinical randomized controlled trials(RCTs) of SJG combined with western medicine against GDM. The included RCTs were assessed for risks using the assessment criteria recommended by the Cochrane handbook for systematic reviews of interventions. Meta-analysis was performed using Stata 12.0 and RevMan 5.3. Nineteen RCTs were included, with 1 647 patients involved, including 824 cases treated with western medicine alone, and 823 cases treated with SJG combined with western medicine. The course of treatment ranged from 2 to 12 weeks. As revealed by Meta-analysis results, compared with western medicine treatment alone, SJG combined with western medicine could reduce the incidence of postpartum hemorrhage(OR=0.23, 95%CI[0.10, 0.53], P=0.000 6), gestational hypertension(OR=0.24, 95%CI[0.13, 0.45], P<0.000 01), polyhydramnios(OR=0.24, 95%CI[0.12, 0.45], P<0.000 1), premature rupture of membranes(OR=0.20, 95%CI[0.09, 0.45], P<0.000 1), cesarean section(OR=0.40, 95%CI[0.29, 0.55], P<0.000 01), macrosomia(OR=0.19, 95%CI[0.08, 0.47], P<0.000 3), neonatal asphyxia(OR=0.22, 95%CI[0.12, 0.40], P<0.000 01), premature delivery(OR=0.19, 95%CI[0.12, 0.30], P<0.000 01), proteinuria(OR=0.19, 95%CI[0.06, 0.58], P=0.004) and hypoglycemia(OR=0.28, 95%CI[0.16, 0.50], P<0.000 1). The funnel plots and Egger's test showed that except macrosomia, there was no significant publication bias in the results of other indicators. Therefore, as indicated by the findings, SJG combined with western medicine can reduce the incidence of adverse pregnancy outcomes in GDM patients. However, due to the uneven quality of the included trials, the clinical application of this protocol requires caution.
Asunto(s)
Diabetes Gestacional , Cesárea , Diabetes Gestacional/tratamiento farmacológico , Medicamentos Herbarios Chinos , Femenino , Macrosomía Fetal , Humanos , Recién Nacido , Embarazo , Resultado del Embarazo , Revisiones Sistemáticas como AsuntoRESUMEN
Objective To evaluate the effects of vitamin D supplementation on serum lipid profiles and neonatal prognosis in gestational diabetes mellitus(GDM)patients.Methods The electronic databases including PubMed,Web of Science,Embase,CNKI,and Wanfang Data were searched from inception to February 1,2020.All randomized controlled trials that compared vitamin D supplementation with placebo or without supplementation for GDM women were included.Paper selection,data extraction,meta-analysis and sensitivity analysis were conducted independently by two authors.Risk of bias was assessed using the Cochrane Risk of Bias Tool.The data were analyzed in RevMan 5.3 software and Stata 12.0.Results Totally 17 randomized controlled trials involving 1432 patients(704 in the intervention group and 728 in the control group)were included in the meta-analysis.The results showed that vitamin D supplementation significantly reduced serum total cholesterol [MD=-6.11,95% CI=(-7.17,-5.04)],low-density lipoprotein cholesterol [MD=-10.80,95% CI=(-14.72,-6.89)],and triglyceride [MD=-8.11,95% CI=(-10.09,-6.13)],while significantly increased serum 25-hydroxyvitamin D3 level [MD=45.45,95% CI=(41.98,48.92)] and high-density lipoprotein cholesterol [MD=2.77,95% CI=(1.59,3.96)].In addition,vitamin D supplementation significantly reduced the incidence rate of hyperbilirubinemia [RR=0.49,95% CI=(0.35,0.68)],premature birth [RR=0.44,95% CI=(0.27,0.72)],and neonatal hospitalization [RR=0.44,95% CI=(0.29,0.67)].Conclusions Vitamin D supplementation may regulate the serum lipid profiles in patients with GDM and reduce the incidence of adverse neonatal outcomes.More high-quality RCTs are needed to confirm the findings in our study.
Asunto(s)
Diabetes Gestacional , Nacimiento Prematuro , Diabetes Gestacional/tratamiento farmacológico , Suplementos Dietéticos , Femenino , Humanos , Recién Nacido , Embarazo , Ensayos Clínicos Controlados Aleatorios como Asunto , Vitamina D , VitaminasRESUMEN
Grandparents caring for grandchildren has become a common experience in China. However, the health implications of grandparenting, especially for health self-management, remain unclear. A cross-sectional study was conducted to investigate the effects of grandparenting on health self-management in older adults in China. Information on socioeconomic characteristics, grandparenting, and health self-management was collected through interviewer-administered questionnaires. Age less than 50, male gender, higher education level, being a local resident, having a chronic illness, and supporting themselves financially were all factors that were significantly positively associated with health self-management (P < .05) in grandparents. Grandparenting characteristics, including caring for grandchildren at night, a caregiving burden of more than 50%, poorly behaved grandchildren, caring for grandchildren more than 6 hours per day, and caring for grandchildren less than 1 year in age were significantly negatively associated with health self-management in grandparents (P < .05). Multiple regression analyses indicated that grandparent age, receiving financial support from children, being a local resident, education level, grandchild behavior and age, and being an urban resident were all statistically significant factors associated with health self-management in grandparents involved in grandparenting. Taken together, these results suggested that financial condition and caregiving burden might be the major factors affecting health self-management in grandparents involved in grandparenting.
Asunto(s)
Cuidado del Niño , Abuelos , Automanejo , Factores de Edad , Anciano , Niño , Cuidado del Niño/métodos , Cuidado del Niño/psicología , Cuidado del Niño/estadística & datos numéricos , Preescolar , China , Escolaridad , Femenino , Abuelos/psicología , Humanos , Lactante , Masculino , Persona de Mediana Edad , Factores Socioeconómicos , Encuestas y CuestionariosRESUMEN
The aim of the present study was to evaluate the effects of lutein and lycopene supplementation on carotid artery intima-media thickness (CAIMT) in subjects with subclinical atherosclerosis. A total of 144 subjects aged 45-68 years were recruited from local communities. All the subjects were randomly assigned to receive 20 mg lutein/d (n 48), 20 mg lutein/d+20 mg lycopene/d (n 48) or placebo (n 48) for 12 months. CAIMT was measured using Doppler ultrasonography at baseline and after 12 months, and serum lutein and lycopene concentrations were determined using HPLC. Serum lutein concentrations increased significantly from 0·34 to 1·96 µmol/l in the lutein group (P< 0·001) and from 0·35 to 1·66 µmol/l in the combination group (P< 0·001). Similarly, serum lycopene concentrations increased significantly from 0·18 to 0·71 µmol/l in the combination group at month 12 (P< 0·001), whereas no significant change was observed in the placebo group. The mean values of CAIMT decreased significantly by 0·035 mm (P= 0·042) and 0·073 mm (P< 0·001) in the lutein and combination groups at month 12, respectively. The change in CAIMT was inversely associated with the increase in serum lutein concentrations (P< 0·05) in both the active treatment groups and with that in serum lycopene concentrations (ß = - 0·342, P= 0·031) in the combination group. Lutein and lycopene supplementation significantly increased the serum concentrations of lutein and lycopene with a decrease in CAIMT being associated with both concentrations. In addition, the combination of lutein and lycopene supplementation was more effective than lutein alone for protection against the development of CAIMT in Chinese subjects with subclinical atherosclerosis, and further studies are needed to confirm whether synergistic effects of lutein and lycopene exist.
Asunto(s)
Antioxidantes/uso terapéutico , Aterosclerosis/dietoterapia , Carotenoides/uso terapéutico , Arteria Carótida Común/diagnóstico por imagen , Suplementos Dietéticos , Luteína/uso terapéutico , Anciano , Antioxidantes/efectos adversos , Antioxidantes/análisis , Aterosclerosis/sangre , Aterosclerosis/diagnóstico por imagen , Aterosclerosis/fisiopatología , Carotenoides/efectos adversos , Carotenoides/sangre , Grosor Intima-Media Carotídeo , China , Suplementos Dietéticos/efectos adversos , Método Doble Ciego , Diagnóstico Precoz , Femenino , Humanos , Perdida de Seguimiento , Luteína/efectos adversos , Luteína/sangre , Licopeno , Masculino , Persona de Mediana Edad , Pacientes Desistentes del Tratamiento , Índice de Severidad de la Enfermedad , Factores de Tiempo , Salud UrbanaRESUMEN
BACKGROUND: Radiotherapy is the standard and most effective treatment for nasopharyngeal carcinoma (NPC) in its early stages. However, its application in fighter pilots returning to flying duties with NPC has not been previously reported, presumably due to post-radiotherapeutic complications. CASE REPORT: A 36-yr-old male fighter pilot had a painless mass in the left neck for 5 mo. Pathological diagnosis demonstrated nonkeratinizing squamous cell carcinoma in the left nasopharynx which had metastasized to lymph nodes in the left side of the neck. He was diagnosed and staged with NPC (T1N2M0) before treatment with radiotherapy and adjuvant chemotherapy. The patient suffered from catarrhal otitis media and xerostomia after 3 mo of radiotherapy, but these symptoms resolved. After a total of 8 mo of radiotherapy, he was in remission with no evidence of tumor recurrence or metastasis. He had normal Eustachian tube, hearing, and vestibular function before and after hypobaric chamber testing and passed all flight-related physical examinations. Consequently, he was granted a medical waiver and returned to flying status in two-seat fighter aircraft, flying for 53 h in a 12-mo period. After passing all flight-related tests again, he was then allowed to fly in single-seat aircraft. At the time of submission of this article, he has flown for 147 h and remained on flying status for 26 mo. He will be monitored annually for long-term effects of radiotherapy and/or disease recurrence. CONCLUSIONS: Fighter pilots with NPC may be safely considered for medical waiver with appropriate monitoring after successful treatment.
Asunto(s)
Medicina Aeroespacial , Personal Militar , Neoplasias Nasofaríngeas/radioterapia , Adulto , Carcinoma , Humanos , Imagen por Resonancia Magnética , Masculino , Carcinoma Nasofaríngeo , Neoplasias Nasofaríngeas/diagnóstico , Nasofaringe/diagnóstico por imagen , Nasofaringe/patología , Orofaringe/efectos de la radiación , Otitis Media/etiología , Radioterapia de Intensidad Modulada/efectos adversos , Tomografía Computarizada por Rayos X , Enfermedades Vestibulares/etiología , Xerostomía/etiologíaRESUMEN
Lung adenocarcinoma (LUAD) is the predominant type of non-small lung cancer (NSCLC) with strong invasive ability and poor prognosis. The drug resistance related genes are potentially associated with prognosis of LUAD. Our research aimed to identify the drug resistance related genes and explore their potential prognostic value in LUAD patients. The data used in this study were obtained from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases. Firstly, we screened drug resistance related genes in LUAD by differential gene analysis, univariate Cox regression and drug sensitivity analyses. Subsequently, we constructed a risk score model using LASSO Cox regression analysis, and verified whether the risk score can predict the survival of LUAD patients independent of other factors. Moreover, we explored the immune infiltration of 22 immune cells between high-risk and low-risk patients. Totally 10 drug-resistance positively related genes (PLEK2, TFAP2A, KIF20A, S100P, GDF15, HSPB8, SASH1, WASF3, LAMA3 and TCN1) were identified in LUAD. The risk score model of LUAD constructed with these 10 genes could reliably predict the prognosis of LUAD patients. 18 pathways were significantly activated in high-risk group compared with low-risk group. In addition, the infiltration proportion of multiple immune cells was significantly different between high-risk and low-risk groups, and the proportion of M1 phagocytes was significantly higher in the high-risk group compared with the low-risk group. The drug resistance related genes (PLEK2, TFAP2A, KIF20A, S100P, GDF15, HSPB8, SASH1, WASF3, LAMA3 and TCN1) could predict the prognosis of LUAD patients. Clarifying the roles and mechanisms of these 10 genes in regulating drug resistance in LUAD will help to improve individualized clinical treatment protocols and predict patient sensitivity to treatment.
Asunto(s)
Adenocarcinoma del Pulmón , Neoplasias Pulmonares , Humanos , Microambiente Tumoral/genética , Adenocarcinoma del Pulmón/tratamiento farmacológico , Adenocarcinoma del Pulmón/genética , Pronóstico , Neoplasias Pulmonares/tratamiento farmacológico , Neoplasias Pulmonares/genética , Resistencia a Medicamentos , Proteínas de la Membrana , Familia de Proteínas del Síndrome de Wiskott-AldrichRESUMEN
PURPOSE: To determine whether supplementation with lutein and zeaxanthin improves macular pigment and visual function in patients with early age-related macular degeneration (AMD). DESIGN: Randomized, double-masked, placebo-controlled trial. PARTICIPANTS: Participants with probable AMD who were 50 to 79 years of age were screened for study eligibility from the local communities. One hundred eight subjects with early AMD were recruited. INTERVENTION: Early AMD patients were assigned randomly to receive 10 mg/day lutein (n = 27), 20 mg/day lutein (n = 27), 10 mg/day lutein plus 10 mg/day zeaxanthin (n = 27); or placebo (n = 27) for 48 weeks. Macular pigment optical density (MPOD) and visual function variables were assessed at baseline, 24 weeks, and 48 weeks. MAIN OUTCOME MEASURES: The primary outcome was MPOD. Secondary outcomes were visual function variables including best-corrected visual acuity (BCVA), contrast sensitivity (CS), photorecovery time, and Amsler grid testing results. RESULTS: Macular pigment optical density increased significantly by a mean ± standard error of 0.076 ± 0.022 density unit in the 20-mg lutein group and 0.058 ± 0.027 density unit in the lutein and zeaxanthin group during 48 weeks. There was a significant dose-response effect for lutein supplementation, and the changes in MPOD from baseline to 48 weeks were correlated negatively with baseline MPOD in all active treatment groups (r = -0.56; P<0.001). At 48 weeks, a trend toward improvement was seen in BCVA, and there was a significant between-group difference in CS at 3 and 6 cycles/degree between the 20-mg lutein group and the placebo group. The increase in MPOD related positively to the reduction in the logarithm of the minimum angle of resolution BCVA (r = -0.31; P<0.01) and the increases in CS at 4 spatial frequencies (r ranging from 0.26 to 0.38; all P<0.05). CONCLUSIONS: Among patients with early AMD, supplementation with lutein and zeaxanthin improved macular pigment, which played a causative role in boosting visual function and might prevent the progression of AMD. Future studies are required to evaluate the effect of these carotenoids on the incidence of late AMD.
Asunto(s)
Luteína/administración & dosificación , Degeneración Macular/tratamiento farmacológico , Retina/fisiología , Pigmentos Retinianos/metabolismo , Agudeza Visual/fisiología , Xantófilas/administración & dosificación , Anciano , Sensibilidad de Contraste , Suplementos Dietéticos , Relación Dosis-Respuesta a Droga , Método Doble Ciego , Quimioterapia Combinada , Conducta Alimentaria , Femenino , Humanos , Luteína/metabolismo , Degeneración Macular/metabolismo , Masculino , Persona de Mediana Edad , Estimulación Luminosa , Estudios Prospectivos , Retina/efectos de la radiación , Rodopsina/metabolismo , Encuestas y Cuestionarios , Xantófilas/metabolismo , ZeaxantinasRESUMEN
Lutein and zeaxanthin are thought to decrease the incidence of age-related macular degeneration (AMD); however, findings have been inconsistent. We conducted a systematic literature review and meta-analysis to evaluate the relationship between dietary intake of lutein and zeaxanthin and AMD risk. Relevant studies were identified by searching five databases up to April 2010. Reference lists of articles were retrieved, and experts were contacted. Literature search, data extraction and study quality assessment were performed independently by two reviewers and results were pooled quantitatively using meta-analysis methods. The potential sources of heterogeneity and publication bias were also estimated. The search yielded six longitudinal cohort studies. The pooled relative risk (RR) for early AMD, comparing the highest with the lowest category of lutein and zeaxanthin intake, was 0·96 (95 % CI 0·78, 1·17). Dietary intake of these carotenoids was significantly related with a reduction in risk of late AMD (RR 0·74; 95 % CI 0·57, 0·97); and a statistically significant inverse association was observed between lutein and zeaxanthin intake and neovascular AMD risk (RR 0·68; 95 % CI 0·51, 0·92). The results were essentially consistent among subgroups stratified by participant characteristics. The findings of the present meta-analysis indicate that dietary lutein and zeaxanthin is not significantly associated with a reduced risk of early AMD, whereas an increase in the intake of these carotenoids may be protective against late AMD. However, additional studies are needed to confirm these relationships.
Asunto(s)
Dieta , Luteína/administración & dosificación , Degeneración Macular/epidemiología , Xantófilas/administración & dosificación , Edad de Inicio , Anciano , Medicina Basada en la Evidencia , Humanos , Degeneración Macular/prevención & control , Persona de Mediana Edad , Riesgo , Degeneración Macular Húmeda/epidemiología , Degeneración Macular Húmeda/prevención & control , ZeaxantinasRESUMEN
BACKGROUND: Pulmonary sequestration is a rare congenital malformation. The diagnosis of pulmonary sequestration is based on the identification of an abnormal arterial supply. Conventional treatment for pulmonary sequestration is surgical removal of the tissue, which may induce serious trauma and requires a long recovery time. Recently, endovascular treatment has become feasible as a safer and less invasive method to treat pulmonary sequestration. CASE REPORT: To the best of our knowledge, pulmonary sequestration has not been reported in pilots. In this study, we report a fighter pilot case of intralobar pulmonary sequestration detected with the assistance of spiral computed tomography (CT) and digital subtraction angiography. The young fighter pilot had experienced recurrent hemoptysis and pulmonary infections for approximately 10 yr before the pulmonary sequestration was diagnosed. We performed a transcatheter arterial embolization and a subsequent CT angiography confirmed complete infarction of the sequestration. After the treatment, no clinical complications were observed and the patient, with normal lung function restored, was qualified to serve as a fighter pilot again. DISCUSSION: Compared with conventional removal surgery, endovascular treatment is a superior treatment for pulmonary sequestration in a fighter pilot in maintenance of pilot qualification.
Asunto(s)
Aeronaves , Secuestro Broncopulmonar/diagnóstico por imagen , Personal Militar , Adulto , Angiografía de Substracción Digital , Secuestro Broncopulmonar/terapia , Diagnóstico Diferencial , Embolización Terapéutica , Humanos , Masculino , Tomografía Computarizada EspiralRESUMEN
OBJECTIVE: To establish a simultaneous determination method for measuring lutein, zeaxanthin and ß-carotene in serum by internal standard on C(30)-HPLC. METHODS: Experimental data were as follows: stationary phase, Develosil carotenoid column C(30) (250 mm×4.6 mm, 5 µm); mobile phase A, acetonitrile:methanol (3:2, v/v); mobile phase B, MTBE; grads elution; flow rate, 1 mL/min; monitoring wavelength, 450 nm; injection volume, 20 µL; column temperature, 25 °C. RESULTS: Lutein, zeaxanthin and ß-carotene were thoroughly separated with the average retention time of 9.9 min, 10.3 min and 21.2 min, respectively. The intra-day relative standard deviation (RSD) values were 3.22%, 3.81% and 1.60%. The linear ranges of serum concentrations of lutein and ß-carotene were both 0.012 5-12.5 mg/L (r=0.999 5, r=0.999 7), and that of zeaxanthin was 0.005-5.0 mg/L (r=1). The mean serum concentrations of lutein, zeaxanthin and ß-carotene for 58 healthy elder inhabitants (>50 years) were 0.410 µmol/L, 0.054 µmol/L and 0.128 µmol/L, respectively. CONCLUSION: This established method can be used for determination of lutein, zeaxanthin and ß-carotene in serum.
Asunto(s)
Cromatografía Líquida de Alta Presión , Luteína/sangre , Xantófilas/sangre , Anciano , Cromatografía Líquida de Alta Presión/métodos , Humanos , Zeaxantinas , beta Caroteno/sangreRESUMEN
OBJECTIVE: To measure lutein, zeaxanthin and ß-carotene level in foods commonly consumed in Beijing, and compare the content difference between raw and cooked food. METHODS: Forty-six commonly consumed foods of 8 classes were collected in Haidian district of Beijing from September to October in 2009. A high performance liquid chromatography method was used to determine the content of lutein, zeaxanthin and ß-carotene in both raw and cooked samples. RESULTS: Lutein was abundant in cucurbitaceous and solanaceous, allium and nuts, especially in Chinese chive (18 226.9 µg/100 g) and pumpkin (13 265.2 µg/100 g). Major sources of zeaxanthin included round pumpkin, green garlic shoot, corn and eggs, whose level of zeaxanthin were 444.6, 283.5, 279.7, 118.6 - 377.9 µg/100 g, respectively. Zeaxanthin level of those cooked foods changed to 483.9, 239.3, 279.1, 149.5 - 594.7 µg/100 g, respectively. The zeaxanthin level of cooked Chinese chive reached 1081.2 µg/100 g, while we did not detect any zeaxanthin in raw Chinese chive. ß-carotene was present in a wide variety of vegetables and fruits. Carrot (17 234.3 µg/100 g) was a good source of ß-carotene, while its level in cooked carrot was 17 013.5 µg/100 g. CONCLUSION: Consuming the proper kinds of foods and changing the method of food processing were beneficial to increase the intake of lutein, zeaxanthin and ß-carotene.
Asunto(s)
Alimentos , Luteína/análisis , Xantófilas/análisis , beta Caroteno/análisis , China , Culinaria , Análisis de los Alimentos , ZeaxantinasRESUMEN
We aimed to examine the effect of different doses of lutein supplementation on visual function in subjects with long-term computer display light exposure. Thirty-seven healthy subjects with long-term computer display light exposure ranging in age from 22 to 30 years were randomly assigned to one of three groups: Group L6 (6 mg lutein/d, n 12); Group L12 (12 mg lutein/d, n 13); and Group Placebo (maltodextrin placebo, n 12). Levels of serum lutein and visual performance indices such as visual acuity, contrast sensitivity and glare sensitivity were measured at weeks 0 and 12. After 12-week lutein supplementation, serum lutein concentrations of Groups L6 and L12 increased from 0.356 (SD 0.117) to 0.607 (SD 0.176) micromol/l, and from 0.328 (SD 0.120) to 0.733 (SD 0.354) micromol/l, respectively. No statistical changes from baseline were observed in uncorrected visual acuity and best-spectacle corrected visual acuity, whereas there was a trend toward increase in visual acuity in Group L12. Contrast sensitivity in Groups L6 and L12 increased with supplementation, and statistical significance was reached at most visual angles of Group L12. No significant change was observed in glare sensitivity over time. Visual function in healthy subjects who received the lutein supplement improved, especially in contrast sensitivity, suggesting that a higher intake of lutein may have beneficial effects on the visual performance.
Asunto(s)
Terminales de Computador , Luteína/administración & dosificación , Visión Ocular/efectos de los fármacos , Adulto , Análisis de Varianza , Pueblo Asiatico , Distribución de Chi-Cuadrado , Sensibilidad de Contraste/efectos de los fármacos , Suplementos Dietéticos , Método Doble Ciego , Femenino , Deslumbramiento/efectos adversos , Humanos , Luteína/sangre , Masculino , Estudios Prospectivos , Resultado del Tratamiento , Agudeza Visual/efectos de los fármacos , Adulto JovenRESUMEN
INTRODUCTION: Milk is a good source of bioavailable calcium compared with other foods. Recent in vitro and in vivo studies have shown that milk whey protein, especially its basic protein fraction (milk basic protein, MBP), contains several components capable of promoting bone formation and inhibiting bone resorption. The objective of this study was to examine the effects of MBP on bone mineral density (BMD) and bone metabolism of healthy young women. METHODS: Eighty-four healthy young women were randomly assigned to three groups: control group, whole milk group or MBP group treated with milk containing 40 mg MBP for 8 months. The bone mineral density of total body, the lumbar vertebrae L2-L4 and the left forearm of each subject were measured by dual-energy X-ray absorptiometry (DEXA) at 0 and 8 months of treatment. Serum indexes of bone metabolism were measured at 0, 3, 6 and 8 months. Eighty-one subjects who completed the study in accordance with the protocol were included in the analysis. RESULTS: Total BMD in all groups significantly increased compared with baseline values. However, no significant difference on the mean rate of gain of total BMD was observed among the MBP group (2.19%), the whole milk group (2.63%) and the control group (1.61%). Serum cross-linked N-teleopeptides of type-I collagen (NTx) in MBP group at 8 months and in whole milk group at 6 months were significantly decreased from baseline. There were no significant differences between whole milk group and MBP group; however, after combining the milk groups, NTx had significantly decreased from baseline. No significant increase was observed in serum bone-specific alkaline phosphatase (BAP) in both whole milk group and MBP group. CONCLUSION: No significant effect of MBP on bone mineral density and bone metabolism was observed, but milk supplementation was effective in suppressing bone resorption.
Asunto(s)
Densidad Ósea/efectos de los fármacos , Resorción Ósea/prevención & control , Huesos/efectos de los fármacos , Proteínas de la Leche/farmacología , Animales , Densidad Ósea/fisiología , Huesos/metabolismo , China , Suplementos Dietéticos , Femenino , Humanos , Vértebras Lumbares/efectos de los fármacos , Vértebras Lumbares/fisiología , Leche/química , Osteogénesis/efectos de los fármacos , Osteogénesis/fisiología , Proteína de Suero de Leche , Adulto JovenRESUMEN
BACKGROUND: Despite advances in asthma management, exacerbations constitute a significant health economic burden. OBJECTIVE: To observe the efficacy and safety of Chinese herbal medicine formula entitled PingchuanYiqi (PCYQ) granule, on acute asthma and to explore its possible mechanism. MATERIALS AND METHODS: This proof-of-concept study consisted of a randomized, double-blind, placebo-controlled trial in patients with acute asthma (nâ¯=â¯300). Participants with acute mild-to-moderate asthma recruited from seven centers in China were randomly assigned to receive PCYQ or placebo. The primary outcomes were PEF (L/min) and total asthma symptom scores. Furthermore, a panel of cytokines including serum IL-4, IL-5, IL-6, IL-8, IL-1ß, IL-17A, IFN-α, IFN-ß, IFN-γ, CRP, CCL-5, IP-10, and PGD2 levels was detected using ELISA. RESULTS: The PCYQ (nâ¯=â¯139) significantly improved the morning PEF on day 4 (349.73⯱â¯93.92 vs. 313.56⯱â¯92.91â¯L/min, Pâ¯=â¯0.004) and day 7 (360.42⯱â¯94.39 vs. 329.52⯱â¯95.97â¯L/min, Pâ¯=â¯0.023), and the evening PEF on day 4 (352.65⯱â¯95.47 vs. 320.58⯱â¯95.30â¯L/min, Pâ¯=â¯0.012) and day 7 (360.42⯱â¯94.39 vs. 336.86⯱â¯95.59â¯L/min, Pâ¯=â¯0.029) in comparison with the placebo (nâ¯=â¯143). The PCYQ also improved the clinical symptoms scores and reduced the puffs of short-acting ß2-agonist (all Pâ¯<â¯0.05). Furthermore, the PCYQ statistically reduced IL-5, IL-8, IL-1ß and PGD2 in serum. CONCLUSION: The PCYQ as the Chinese herbal medicine formula significantly improves lung function and symptoms of acute asthma, and reduces SABA dosage possibly via decrease of inflammatory biomarkers such as IL-5, IL-8, IL-1ß and PGD2. TRIAL REGISTRATION: ISRCTN61674768 (http://www.isrctn.com/).
Asunto(s)
Antiasmáticos/uso terapéutico , Asma/tratamiento farmacológico , Medicamentos Herbarios Chinos/uso terapéutico , Enfermedad Aguda , Adolescente , Adulto , Anciano , Albuterol/administración & dosificación , Antiasmáticos/efectos adversos , Asma/inmunología , Asma/fisiopatología , Biomarcadores/sangre , Broncodilatadores/administración & dosificación , Citocinas/sangre , Método Doble Ciego , Esquema de Medicación , Quimioterapia Combinada , Medicamentos Herbarios Chinos/efectos adversos , Femenino , Humanos , Masculino , Persona de Mediana Edad , Ápice del Flujo Espiratorio/efectos de los fármacos , Prueba de Estudio Conceptual , Índice de Severidad de la Enfermedad , Adulto JovenRESUMEN
There is evidence that bipolar disorder (BD) patients with an unhealthy lifestyle have a worse course of illness. This study was designed to examine the extent to which lifestyle could influence the severity of clinical symptoms associated with BD. A total of 113 BD patients were recruited in this study. The lifestyle information including data on dietary patterns, physical activity, and sleep quality were collected using a self-rated questionnaire. The results showed that the consumption of whole grain, seafood, and dairy products were significantly negatively correlated with the 17-item Hamilton Rating Scale for Depression (HAMD-17) total score. The consumption of sugar, soft drinks, and alcohol as well as being a current smoker were positively correlated with the severity of clinical symptoms. Multiple linear regression and binary logistic regression analyses demonstrated an independent negative correlation between both whole grain and dairy product consumption with the HAMD-17 score. The results from the current study suggested that lifestyle factors, especially dietary patterns, might be associated with clinical symptoms of BD. The association between the consumption of specific foods and severity of depressive symptoms may offer some useful information and further understanding of the role of lifestyle factors in the development of BD.
Asunto(s)
Pueblo Asiatico/psicología , Trastorno Bipolar/diagnóstico , Trastorno Bipolar/psicología , Conducta Alimentaria/psicología , Estilo de Vida , Adolescente , Adulto , Trastorno Bipolar/epidemiología , Estudios Transversales , Femenino , Humanos , Masculino , Persona de Mediana Edad , Escalas de Valoración Psiquiátrica , Encuestas y Cuestionarios , Adulto JovenRESUMEN
OBJECTIVE: To investigate the relationships between the expression of estrogen receptor beta (ERbeta) and etiology of human endometrial polyps (EP). METHODS: Thirty-six females with infertility and 36 females with intrauterine contraceptive device (IUD, aged from 23 years to 33 years, average 28 years) were enrolled in the study. Blood samples were taken before hysteroscopy for analysis of the level of estradiol in serum. All the tissue samples of benign EP and endometrium in the same cycle were obtained through hysteroscopy on the 5th to 9th days of menstruation cycle (all the women selected had the same menstrual period). Part of the samples of EP were made into homogenates to assay the level of estradiol, and the rest of EP and endometrium were both fixed with 10% formalin. If one of the samples was confirmed by histopathologic analysis, the correspondence was eligible. Otherwise, they were abnegated. Seventy-two samples were collected and 60 were eligible as a result. The expression of ERbeta and ERalpha in these samples was detected by immunohistochemical staining, while the levels of estradiol in both serum and homogenate of EP were detected by radioimmunoassay. RESULTS: The expression of stromal ERbeta of EP in infertility and IUD groups (2.1 +/- 0.9, 1.9 +/- 0.5) was significantly higher than those of endometrium in the same cycle (1.7 +/- 0.3, 1.3 +/- 1.1) (P < 0.05), while the expression of stromal ERalpha of EP was significantly decreased than those of endometrium (P > 0.05). The expression of ERbeta in glands had no difference in both EP and endometrium. The expression of ERbeta was significantly positively related to the levels of estradiol in both serum and homogenate (P < 0.01), while the expression of ERalpha had no correlation with estradiol. CONCLUSIONS: Overexpression of ERbeta in stroma might play an important role in the pathogenesis of EP.
Asunto(s)
Endometrio/metabolismo , Receptor beta de Estrógeno/metabolismo , Pólipos/etiología , Enfermedades Uterinas/etiología , Adulto , Estradiol/sangre , Receptor alfa de Estrógeno/metabolismo , Femenino , Humanos , Inmunohistoquímica , Ciclo Menstrual/fisiología , Pólipos/metabolismo , Radioinmunoensayo , Células del Estroma/metabolismo , Enfermedades Uterinas/metabolismoRESUMEN
BACKGROUND: Ménière's disease (MD) is defined as an idiopathic disorder of the inner ear characterized by the triad of tinnitus, vertigo, and sensorineural hearing loss. Although many studies have evaluated the association between variants in the KCNE1 or KCNE3 gene and MD risk, debates still exist. OBJECTIVE: Our aim is to evaluate the association between KCNE gene variants, including KCNE1 rs1805127 and KCNE3 rs2270676, and the risk of MD by a systematic review. METHODS: We searched the literature in PubMed, SCOPUS and EMBASE through May 2015. We calculated pooled odds ratios (OR) and 95% confidence intervals (CIs) using a fixed-effects model or a random-effects model for the risk to MD associated with different KCNE gene variants. The heterogeneity assumption decided the effect model. RESULTS: A total of three relevant studies, with 302 MD cases and 515 controls, were included in this meta-analysis. The results indicated that neither the KCNE1 rs1805127 variant (for G vs. A: OR = 0.724, 95%CI 0.320, 1.638, P= 0.438), nor the KCNE3 rs2270676 variant (for T vs. C: OR = 0.714, 95%CI 0.327, 1.559, P = 0.398) was associated with MD risk. CONCLUSIONS: Based on current evidence from published studies, neither of the two variants from KCNE was significantly associated with the risk of MD. Larger studies with mixed ethnicity subjects and stratified by clinical and sub-clinical characteristics are needed to validate our findings.
Asunto(s)
Enfermedad de Meniere/genética , Canales de Potasio con Entrada de Voltaje/genética , Variación Genética , HumanosRESUMEN
PURPOSE: To compare the 2-year effect of multiple doses of lutein/zeaxanthin on serum, macular pigmentation, and visual performance on patients with early age-related macular degeneration (AMD). METHODS: In this randomized, double-blinded, and placebo-controlled trial, 112 early AMD patients randomly received either 10 mg lutein, 20 mg lutein, a combination of lutein (10 mg) and zeaxanthin (10 mg), or placebo daily for 2 years. Serum concentration of lutein/zeaxanthin, macular pigment optical density (MPOD), visual functions including best-spectacle corrected visual acuity (BCVA), contrast sensitivity (CS), flash recovery time (FRT), and vision-related quality of life (VFQ25) was quantified. RESULTS: Serum lutein concentration and MPOD significantly increased in all the active treatment groups. Supplementation with 20 mg lutein was the most effective in increasing MPOD and CS at 3 cycles/degree for the first 48 weeks. However, they both significantly increased to the same peak value following supplementation with either 10 mg or 20 mg lutein during the intervention. No statistical changes of BCVA or FRT were observed during the trial. CONCLUSIONS: Long-term lutein supplementation could increase serum lutein concentration, MPOD, and visual sensitivities of early AMD patients. 10 mg lutein daily might be an advisable long-term dosage for early AMD treatment.